Compare CRWS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWS | VRCA |
|---|---|---|
| Founded | 1957 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 32.7M |
| IPO Year | N/A | 2018 |
| Metric | CRWS | VRCA |
|---|---|---|
| Price | $2.93 | $7.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 40.7K | ★ 185.1K |
| Earning Date | 02-11-2026 | 11-14-2025 |
| Dividend Yield | ★ 11.19% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,751,000.00 | $30,829,000.00 |
| Revenue This Year | N/A | $373.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 234.73 |
| 52 Week Low | $2.35 | $3.28 |
| 52 Week High | $4.55 | $9.82 |
| Indicator | CRWS | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 65.68 | 47.90 |
| Support Level | $2.75 | $7.79 |
| Resistance Level | $2.93 | $8.27 |
| Average True Range (ATR) | 0.07 | 0.60 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 93.94 | 7.24 |
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.